DS
GMED icon

David Shaw’s Globus Medical GMED Stock Holding History

David Shaw’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$656K Sell
8,300
-20,059
-71% -$1.7M ﹤0.01% 4033
2026
Q1 		$2.44M Sell
28,359
-59,850
-68% -$5.37M ﹤0.01% 2759
2025
Q4 		$7.7M Sell
88,209
-117,964
-57% -$8.95M ﹤0.01% 1975
2025
Q3 		$11.8M Buy
+206,173
New +$11.9M 0.01% 1553
2023
Q4 		– Sell
-546,754
Closed -$27.1M – 4415
2023
Q3 		$27.1M Buy
546,754
+518,756
+1,853% +$29M 0.03% 689
2023
Q2 		$1.67M Buy
27,998
+237
+0.9% +$13.5K ﹤0.01% 2747
2023
Q1 		$1.57M Buy
27,761
+17,035
+159% +$1.09M ﹤0.01% 2856
2022
Q4 		$797K Buy
10,726
+1,785
+20% +$122K ﹤0.01% 3589
2022
Q3 		$533K Buy
+8,941
New +$538K ﹤0.01% 4003
2022
Q1 		– Sell
-4,531
Closed -$327K – 5678
2021
Q4 		$327K Buy
+4,531
New +$329K ﹤0.01% 4640
2020
Q2 		– Sell
-40,028
Closed -$1.7M – 4080
2020
Q1 		$1.7M Buy
+40,028
New +$1.98M ﹤0.01% 2306
2019
Q4 		– Sell
-6,300
Closed -$322K – 4026
2019
Q3 		$322K Buy
+6,300
New +$300K ﹤0.01% 3429
2019
Q1 		– Sell
-4,860
Closed -$210K – 3714
2018
Q4 		$210K Sell
4,860
-1,620
-25% -$80.8K ﹤0.01% 3523
2018
Q3 		$368K Buy
+6,480
New +$341K ﹤0.01% 3271
2016
Q1 		– Sell
-7,343
Closed -$204K – 3549
2015
Q4 		$204K Buy
+7,343
New +$184K ﹤0.01% 3551
2014
Q4 		– Sell
-25,853
Closed -$509K – 4088
2014
Q3 		$509K Sell
25,853
-218,567
-89% -$4.5M ﹤0.01% 3339
2014
Q2 		$5.85M Buy
+244,420
New +$5.9M 0.01% 1498

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

David Shaw's GMED Position: Q2 2026 in Review

David Shaw reduced its Globus Medical (GMED) stake by 71% in Q2 2026, selling an estimated $1.7M and leaving 8,300 shares worth $656K. The position accounts for ﹤0.01% of the portfolio, ranked #4033.

David Shaw first reported a position in GMED in Q2 2014 and has held it in 17 quarters since. The position peaked at $27.1M in Q3 2023. 593 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • David Shaw held 8,300 shares of Globus Medical worth $656K as of Q2 2026.
  • David Shaw sold 20,059 Globus Medical shares in Q2 2026, an estimated $1.7M.
  • Globus Medical made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4033 holding.
  • David Shaw first reported a position in Globus Medical in Q2 2014 and has held it in 17 quarters since.
  • David Shaw's Globus Medical position peaked at $27.1M in Q3 2023.
  • 593 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.